Log in to save to my catalogue

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244399

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes

About this item

Full title

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2017-01, Vol.7 (1), p.39121-39121, Article 39121

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Constitutive activation of the Wnt pathway/β-catenin signaling may be important in aldosterone-producing adenoma (APA). However, significant gaps remain in our understanding of the prevalence and clinical outcomes after adrenalectomy in APA patients harboring
CTNNB1
mutations. The molecular expression of CYP11B2 and gonadal receptors in adeno...

Alternative Titles

Full title

The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244399

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244399

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep39121

How to access this item